JP5572310B2 - Manufacturing method of needle-shaped body - Google Patents

Manufacturing method of needle-shaped body Download PDF

Info

Publication number
JP5572310B2
JP5572310B2 JP2008324052A JP2008324052A JP5572310B2 JP 5572310 B2 JP5572310 B2 JP 5572310B2 JP 2008324052 A JP2008324052 A JP 2008324052A JP 2008324052 A JP2008324052 A JP 2008324052A JP 5572310 B2 JP5572310 B2 JP 5572310B2
Authority
JP
Japan
Prior art keywords
water
needle
resin
pedestal portion
plate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008324052A
Other languages
Japanese (ja)
Other versions
JP2010142473A (en
Inventor
由美子 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Toppan Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Toppan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc, Toppan Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP2008324052A priority Critical patent/JP5572310B2/en
Publication of JP2010142473A publication Critical patent/JP2010142473A/en
Application granted granted Critical
Publication of JP5572310B2 publication Critical patent/JP5572310B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046Solid microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053Methods for producing microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Description

本発明は、針状体の製造方法に関するものであり、特に、針状体の台座部に空孔を備える針状体の複製方法に関する。   The present invention relates to a method for manufacturing a needle-like body, and more particularly, to a method for duplicating a needle-like body having a hole in a base portion of the needle-like body.

皮膚上から薬剤を浸透させることによって体内に薬剤を投与する経皮吸収法は、人体に痛みを与えることなく簡便に薬剤を投与することができる方法として用いられている。しかしながら、薬剤の種類によっては経皮吸収法で投与が困難な薬剤が存在する。これらの薬剤を効率よく体内に吸収させる方法として、ミクロンオーダーの微細な針状体を用いて皮膚を穿孔し、皮膚内に直接薬剤を投与する方法が注目されている。   The percutaneous absorption method in which a drug is administered into the body by permeating the drug from the skin is used as a method by which the drug can be easily administered without causing pain to the human body. However, depending on the type of drug, there are drugs that are difficult to administer by the transdermal absorption method. As a method of efficiently absorbing these drugs into the body, a method of perforating the skin using micron-order fine needles and administering the drug directly into the skin has attracted attention.

針状体は、バリア機能を有する表皮(より具体的には表皮の最外層に形成されている角質層)に穿孔を形成し、その穿孔から通常の経皮吸収では表皮のバリア機能に阻害されて投与不可能な薬剤をも体内に吸収させることができる。この方法によれば、投薬用の特別な機器を用いることなく、簡便に薬剤を皮下投薬することが可能となる(特許文献1)。   The acicular body forms perforations in the epidermis having a barrier function (more specifically, the stratum corneum formed in the outermost layer of the epidermis), and normal percutaneous absorption from the perforations is inhibited by the barrier function of the epidermis. Even drugs that cannot be administered can be absorbed into the body. According to this method, it is possible to simply administer a drug subcutaneously without using a special device for dosing (Patent Document 1).

この際に用いる微細な針状体の形状は、皮膚を穿孔するための十分な細さと先端角、および皮下に薬液を浸透させるための十分な長さを有していることが必要とされ、針の直径は数μmから数百μm、針の長さは皮膚の最外層である角質層を貫通し、かつ神経層へ到達しない長さ、具体的には数十μmから数百μm程度、針の先端角度は鋭角なもの、具体的には30°以下、であることが望ましいとされている。   The shape of the fine needle-like body used at this time is required to have a sufficient fineness and tip angle for piercing the skin and a sufficient length for allowing the drug solution to penetrate subcutaneously, The diameter of the needle is several μm to several hundred μm, and the length of the needle penetrates the stratum corneum, which is the outermost layer of the skin, and does not reach the nerve layer, specifically several tens μm to several hundred μm, The tip angle of the needle is preferably an acute angle, specifically, 30 ° or less.

より具体的には、最外皮層である角質層を貫通することが求められる。角質層の厚さは人体の部位によっても若干異なるが、平均して20μm程度である。また、角質層の下にはおよそ200μmから350μm程度の厚さの表皮が存在し、さらにその下層には毛細血管が張りめぐる真皮層が存在する。このため、角質層を貫通させ薬液を浸透させるためには少なくとも20μm以上の針が必要となる。   More specifically, it is required to penetrate the stratum corneum that is the outermost skin layer. The thickness of the stratum corneum varies slightly depending on the part of the human body, but is about 20 μm on average. In addition, an epidermis having a thickness of about 200 μm to 350 μm exists under the stratum corneum, and further, a dermis layer in which capillaries are stretched exists under the epidermis. For this reason, in order to penetrate the stratum corneum and allow the chemical solution to penetrate, a needle of at least 20 μm or more is required.

また、上述した微細な針状体を構成する材料としては、仮に破損した針状体が体内に残留した場合でも、人体に悪影響を及ぼさない材料であることが望ましく、材料としてはマルトース、ポリ乳酸、デキストラン等の生体適合性材料が有望視されている(特許文献2)。   In addition, the material constituting the fine needle-shaped body is preferably a material that does not adversely affect the human body even if the damaged needle-shaped body remains in the body. Examples of the material include maltose and polylactic acid. Biocompatible materials such as dextran are considered promising (Patent Document 2).

近年、薬物を過剰に投与することなく、必要最小限の薬物を、必要な場所に、必要な時に供給することを目的とした、ドラッグデリバリーシステムと呼ばれる薬物投与方法が注目を集めている。前述の針状体上に薬物を塗布したものを皮膚に貼付することにより、特別な機械を用いることなく、薬物を患部に選択的に導入し、さらに一定期間にわたって一定速度で薬物を徐放することが可能となる。
特開平6−192068号公報 特開2005−21677号公報
2. Description of the Related Art In recent years, a drug administration method called a drug delivery system, which aims to supply a necessary minimum amount of drug to a necessary place at a necessary time without excessively administering the drug, has attracted attention. By applying the above-mentioned needle-shaped body coated with a drug to the skin, the drug is selectively introduced into the affected area without using a special machine, and the drug is gradually released at a constant rate over a certain period. It becomes possible.
Japanese Patent Application Laid-Open No. 6-192068 Japanese Patent Laid-Open No. 2005-21677

針状体は、目的部位に的確な穿刺を行って体内に十分な薬剤を投与するために、前記針状体の台座部にアレイ状に配置された複数の微小針が安定した構造を有している必要がある。複数の微小針が安定した構造をとるためには、針状体の台座部の厚みを増加し、前記台座部の変形を最小限に抑制する必要がある。前記台座部の変形を最小限に抑制することによって、使用前に前記微小針同士が接触して針先が損傷してしまい、必要量が投与できなくなるといった問題を解消することができる。   The needle-shaped body has a structure in which a plurality of microneedles arranged in an array on the pedestal of the needle-shaped body is stable in order to accurately puncture the target site and administer a sufficient amount of medicine into the body. Need to be. In order for the plurality of microneedles to have a stable structure, it is necessary to increase the thickness of the pedestal portion of the needle-like body and suppress deformation of the pedestal portion to a minimum. By suppressing the deformation of the pedestal portion to the minimum, it is possible to solve the problem that the microneedles come into contact with each other before use and the needle tip is damaged, making it impossible to administer the required amount.

しかしながら、前記針状体の台座部の厚みを増加すると、気体透過性能、特に、水蒸気透過性能が低下してしまう。前記針状体は、目的部位に的確な穿刺を行って体内に十分な薬剤を投与するために、長時間にわたって皮膚に貼り付けることが想定されるため、水蒸気透過性能が低下した針状体は、発汗による蒸れを生じさせ、皮膚刺激をもたらすおそれがある。   However, when the thickness of the pedestal portion of the needle-like body is increased, gas permeation performance, particularly water vapor permeation performance is degraded. Since the needle-like body is assumed to be stuck to the skin for a long time in order to accurately puncture the target site and administer a sufficient amount of medicine into the body, the needle-like body with reduced water vapor transmission performance is May cause stuffiness due to sweating and skin irritation.

本発明の目的は、十分な厚みをもつ台座部によって前記針状体の微小針部の構造的安定性を確保するとともに、前記台座部に十分な水蒸気透過性能を付与し、皮膚刺激の少ない針状体を製造する方法を提供することにある。   An object of the present invention is to ensure the structural stability of the microneedle portion of the acicular body by a pedestal portion having a sufficient thickness, and to impart sufficient water vapor permeation performance to the pedestal portion so that the needle has little skin irritation. The object of the present invention is to provide a method for manufacturing a state body.

本発明者は、鋭意研究の結果、前記針状体のうち、前記台座部に空孔を偏在させることによって、前記微小針部の構造的安定性と台座部の高い水蒸気透過性能の両方を備える針状体を提供することができることを見出した。   As a result of earnest research, the present inventor has both the structural stability of the microneedle portion and the high water vapor transmission performance of the pedestal portion by unevenly distributing holes in the pedestal portion of the needle-like body. It has been found that needles can be provided.

すなわち、本発明は吸水性樹脂に含水処理を行う前処理工程と、前記含水処理を受けた吸水性樹脂を、針状体の形状を凹凸反転させた微細な凹部を備える複製版の上面に配置し、当該吸水性樹脂の加熱溶融と同時または加熱溶融後に、前記複製版とこれに対向する支持版との間で、前記含水処理を受けた後に溶融した吸水性樹脂を加圧処理することにより、微小針部と台座部とを備えた針状体に成型するとともに、前記吸水性樹脂内の水分を気化して多数の気泡を発生させ、当該気泡を前記台座部に移動させ、前記台座部に空孔が偏在した針状体とする工程と、を含む、針状体の製造方法を提供する。
また、本発明は吸水性樹脂を、針状体の形状を凹凸反転させた微細な凹部を備える複製版の上面に配置し、当該吸水性樹脂を加熱溶融し、この加熱溶融中に前記吸水性樹脂に含水処理を行う工程と、前記加熱溶融と同時または加熱溶融後に、前記複製版とこれに対向する支持版との間で、前記加熱溶融中に含水処理を受けた吸水性樹脂を加圧処理することにより、微小針部と台座部とを備えた針状体に成型するとともに、前記吸水性樹脂内の水分を気化して多数の気泡を発生させ、当該気泡を前記台座部に移動させ、前記台座部に空孔が偏在した針状体とする工程と、を含む、針状体の製造方法を提供する。
さらに、本発明は吸水性樹脂を、針状体の形状を凹凸反転させた微細な凹部を備える複製版の上面に配置する工程と、前記吸水性樹脂の加熱溶融と同時または加熱溶融後に、前記複製版と対向し水分を含浸した支持版を前記吸水性樹脂に接触させ、当該吸水性樹脂に含水処理を行う工程と、前記複製版とこれに対向する支持版との間で、前記吸水性樹脂を加圧処理することにより、微小針部と台座部とを備えた針状体に成型するとともに、前記吸水性樹脂内の水分を気化して多数の気泡を発生させ、当該気泡を前記台座部に移動させ、前記台座部に空孔が偏在した針状体とする工程と、を含む、針状体の製造方法を提供する。
That is, the present invention arranges the pretreatment step of performing water treatment on the water-absorbent resin and the water-absorbent resin subjected to the water treatment on the upper surface of the replication plate having fine concave portions obtained by reversing the shape of the needle-like body. Then, after the water-absorbing resin is heated and melted, or after the heat-melting , the water-absorbing resin that has been melted after being subjected to the water-containing treatment is subjected to pressure treatment between the duplicate plate and the supporting plate facing the replica plate. To form a needle-like body having a microneedle portion and a pedestal portion, vaporize moisture in the water-absorbent resin to generate a large number of bubbles, move the bubbles to the pedestal portion, and A method for producing a needle-like body, comprising a step of forming a needle-like body in which holes are unevenly distributed in a portion.
In the present invention, the water-absorbing resin is disposed on the upper surface of the replication plate having fine concave portions in which the shape of the needle-like body is inverted, and the water-absorbing resin is heated and melted. and performing water treatment resin, the heat-melted simultaneously with or after heating melted, between the support plate facing the and to this duplication plate, pressurized water absorbent resin having undergone the water treatment in the heating and melting By pressure treatment, it is molded into a needle-like body having a microneedle part and a pedestal part, and moisture in the water absorbent resin is vaporized to generate a large number of bubbles, and the bubbles are moved to the pedestal part. And providing a needle-like body in which pores are unevenly distributed in the pedestal portion.
Furthermore, the present invention is a step of placing the water-absorbing resin on the upper surface of the replication plate provided with a fine concave portion obtained by reversing the shape of the needle-like body, and at the same time or after the heat-melting of the water-absorbing resin , The water absorbing resin is disposed between the step of contacting the water-absorbing resin with a support plate impregnated with moisture facing the replica plate and subjecting the water- absorbent resin to water treatment, and the replica plate and the support plate facing the water-repellent plate. By pressurizing the functional resin, it is molded into a needle-like body having a microneedle portion and a pedestal portion, and water in the water-absorbent resin is vaporized to generate a large number of bubbles. And moving to a pedestal portion, and providing a needle-like body in which holes are unevenly distributed in the pedestal portion.

本発明の針状体の製造方法によって、微小針部が構造的安定性を有し、かつ台座部に十分な水蒸気透過性能が付与された針状体を提供することができる。前記針状体は、微小針部が構造的安定性を有するので、全ての針を目的部位に的確に穿刺し、規定量の薬剤を確実に投与することが可能になる。また、前記針状体は、台座部に十分な水蒸気透過性能が付与されているので、皮膚刺激が少なく、長時間にわたる皮膚貼付が可能となる。   According to the method for producing a needle-like body of the present invention, it is possible to provide a needle-like body in which the microneedle portion has structural stability and sufficient water vapor transmission performance is imparted to the pedestal portion. In the needle-like body, since the microneedle portion has structural stability, it becomes possible to accurately puncture all the needles to the target site and reliably administer the prescribed amount of medicine. In addition, since the needle-shaped body is provided with sufficient water vapor transmission performance in the pedestal portion, there is little skin irritation and the skin can be applied for a long time.

以下、本発明の実施態様について説明する。なお、以下に示す実施態様は、本発明の構成を詳細に説明するために例示的に示したものに過ぎない。従って、本発明は、以下の実施態様に記載された説明に基づいて限定解釈されるべきではない。本発明の範囲には、特許請求の範囲に記載された発明の範囲内にある限り、以下の実施態様の種々の変形、改良形態を含む全ての実施態様が含まれる。   Hereinafter, embodiments of the present invention will be described. Note that the embodiments described below are merely examples for explaining the configuration of the present invention in detail. Accordingly, the invention should not be construed as limited based on the description set forth in the following embodiments. The scope of the present invention includes all embodiments including various modifications and improvements of the following embodiments as long as they are within the scope of the invention described in the claims.

図1
図1は、針状体の製造方法を示した模式図である。
FIG.
FIG. 1 is a schematic view showing a method for manufacturing a needle-like body.

図1a
針状体を作製するための樹脂12に低分子量成分を含ませる前処理を行う。前記前処理は、樹脂の溶融前もしくは溶融中のいずれの段階で行ってもよく、また、その前処理方法に特に制限はない。例えば、前記前処理は、気体状態の前記低分子量成分が高濃度で充満している雰囲気下にて、樹脂を静置もしくは樹脂を溶融させ針状体を作製してもよい。例えば、具体的には、低分子量成分が水分の場合、湿度50%以上の環境に放置することにより行っても良い。また、図1bに示すように、樹脂12を複製版11内に充填するとき、樹脂周辺部を気体の低分子量成分で充満させてもよい。
FIG.
A pretreatment is performed in which a low molecular weight component is contained in the resin 12 for producing the needle-like body. The pretreatment may be performed at any stage before or during the melting of the resin, and the pretreatment method is not particularly limited. For example, in the pretreatment, the needle-like body may be produced by allowing the resin to stand still or melting the resin in an atmosphere filled with the low molecular weight component in a gaseous state at a high concentration. For example, specifically, when the low molecular weight component is moisture, the low molecular weight component may be left in an environment having a humidity of 50% or more. Further, as shown in FIG. 1b, when the resin 12 is filled in the replica plate 11, the resin peripheral portion may be filled with a low molecular weight component of gas.

さらに、他の実施形態として、支持版13表面上に低分子量成分を塗布したり、支持版13に低分子量成分を含浸する処理を行った後に、支持版13を樹脂12表面上に接触させてもよい。この場合、樹脂12に対する前処理(図1a)は加熱溶融処理(図1c)および押圧成型処理(図1d)と略同時に行われ、より迅速に針状体1を製造することができる。   Furthermore, as another embodiment, after applying a low molecular weight component on the surface of the support plate 13 or impregnating the support plate 13 with the low molecular weight component, the support plate 13 is brought into contact with the surface of the resin 12. Also good. In this case, the pretreatment (FIG. 1a) for the resin 12 is performed substantially simultaneously with the heat melting treatment (FIG. 1c) and the press molding treatment (FIG. 1d), and the needle-like body 1 can be manufactured more quickly.

樹脂12は生体適合性樹脂であることが望ましい。具体例として、これに限定するものではないが、例えば、医療用シリコーン樹脂、澱粉樹脂、ポリ乳酸(PLA)、ポリグリコール酸(PGA)、ポリ乳酸グリコール酸共重合体、ポリウレタン、ポリ−ε−カプロラクトン、ポリトリメチレンカーボネート、カゼインプラスチック、およびポリエーテルポリエステル共重合体からなる群から選択される。   The resin 12 is preferably a biocompatible resin. Specific examples include, but are not limited to, medical silicone resin, starch resin, polylactic acid (PLA), polyglycolic acid (PGA), polylactic glycolic acid copolymer, polyurethane, poly-ε- It is selected from the group consisting of caprolactone, polytrimethylene carbonate, casein plastic, and polyether polyester copolymer.

また、樹脂12は吸水性樹脂であることが好ましい。吸水性樹脂に含水処理を行い、大量の水を含んだ樹脂を加熱溶融させることによって、樹脂内の水分が気化し、樹脂内に多数の気泡4が発生する。吸水性樹脂は、これに限定するものではないが、その含水率が好ましくは1%以上10%以下である。吸水性樹脂は、人体に悪影響を及ぼさない樹脂であることが望ましく、例えば、生体吸収性樹脂などの生体適合性樹脂が好ましくは用いられる。 The resin 12 is preferably a water-absorbing resin . Water treatment is performed on the water- absorbent resin , and the resin containing a large amount of water is heated and melted, whereby the moisture in the resin is vaporized and a large number of bubbles 4 are generated in the resin. The water absorbent resin is not limited to this, but its water content is preferably 1% or more and 10% or less. The water absorbent resin is desirably a resin that does not adversely affect the human body. For example, a biocompatible resin such as a bioabsorbable resin is preferably used.

低分子量成分は、その沸点もしくは昇華点が、樹脂12の融点よりも低いことが望ましい。分子構造にもよるが、分子量150以下が望ましい。また、樹脂12内部に吸着しやすいような分子構造、官能基を持つものが望ましい。具体例として特に限定するものではないが、水、アルコール類(メタノール、エタノール、プロパノール等)、カルボン酸類(蟻酸、酢酸、プロピオン酸等)、カルボン酸エステル類(酢酸エチル、酢酸メチル、酢酸ペンチル、カプロン酸等)、アルデヒド類(アセトアルデヒド、ベンズアルデヒド等)またはこれらを溶媒として用い、薬剤を溶解させた溶液、もしくはこれらを任意の割合で混合させた溶液を用いてもよい。更に、昇華性をもつ物質、例えば、シュウ酸、カフェイン、サリチル酸などを用いてもよい。   The low molecular weight component desirably has a boiling point or sublimation point lower than the melting point of the resin 12. Although it depends on the molecular structure, a molecular weight of 150 or less is desirable. Further, those having a molecular structure and a functional group that are easily adsorbed inside the resin 12 are desirable. Although not specifically limited as specific examples, water, alcohols (methanol, ethanol, propanol, etc.), carboxylic acids (formic acid, acetic acid, propionic acid, etc.), carboxylic acid esters (ethyl acetate, methyl acetate, pentyl acetate, Caproic acid, etc.), aldehydes (acetaldehyde, benzaldehyde, etc.) or a solution in which these are used as a solvent and a drug is dissolved, or a solution in which these are mixed in an arbitrary ratio may be used. Further, a substance having sublimation properties such as oxalic acid, caffeine, salicylic acid, etc. may be used.

図1b
複製版11上に樹脂12を充填する。樹脂12の充填方法は、これに限定するものではないが、生産性の観点から、インプリント法、ホットエンボス法、射出成形法、押し出し成形法およびキャスティング法を用いることが望ましい。
FIG.
Resin 12 is filled on the duplicate plate 11. The filling method of the resin 12 is not limited to this, but it is desirable to use an imprint method, a hot embossing method, an injection molding method, an extrusion molding method, and a casting method from the viewpoint of productivity.

複製版11は、樹脂12を微小針部2と台座部3とを備えた針状体1に成型するためのものであり、所望する針状体の形状を凹凸反転させた微細な凹部のアレイを備えている。   The duplicate plate 11 is for molding the resin 12 into the needle-like body 1 having the microneedle portion 2 and the pedestal portion 3, and is an array of fine recesses obtained by inverting the shape of the desired needle-like body. It has.

複製版11は、特にこれに限定するものではないが、例えば、工作機械を用いてセラミックス基板を加工し、原版としての針状体を作製後、これを型枠として使用することによって作製される。前記作製された型枠上にシリコーン等の複製版作製材料を注入し、急冷硬化後に型開きを行うことによって、所望の針状体を成型するための凹凸転写パターンを備えた複製版を得ることができる。   The duplicate plate 11 is not particularly limited to this. For example, the replica plate 11 is produced by processing a ceramic substrate using a machine tool, producing a needle-like body as an original plate, and using this as a mold. . By injecting a replica plate-making material such as silicone onto the prepared mold and performing mold opening after quenching and curing, a replica plate having an uneven transfer pattern for molding a desired needle-like body is obtained. Can do.

複製版11は、樹脂11の転写加工成型における転写性、耐久性および離型性などを考慮した材質で作製されている。複製版11の材質は、特に限定するものではないが、銅、ニッケル、シリコン、鉄、アルミ、チタン、クロム、およびこれらを任意の比率で含む合金、ガラス質物質、あるいはテフロン(登録商標)樹脂、シリコーン樹脂、などから選択される。   The duplicate plate 11 is made of a material that takes into account transferability, durability, releasability, and the like in transfer processing molding of the resin 11. The material of the duplicate plate 11 is not particularly limited, but copper, nickel, silicon, iron, aluminum, titanium, chromium, and alloys, vitreous substances, or Teflon (registered trademark) resin containing these in any ratio. , Silicone resin, and the like.

複製版11の剥離性を向上させるために、複製版11の表面上に離型効果を増すための離型層を形成してもよい。離型層としては、例えば広く知られているフッ素系の樹脂を用いることができる。また、離型層の形成方法としては、PVD法、CVD法、スピンコート法およびディップコート法などの薄膜形成手法を好適に用いることができる。離型層を設けることにより、離型時における針状体1の微小針部2の構造的損傷を防止することができ、より精密かつ完全な針状体1を提供することができる。   In order to improve the peelability of the duplicate plate 11, a release layer for increasing the mold release effect may be formed on the surface of the duplicate plate 11. As the release layer, for example, a widely known fluorine-based resin can be used. Further, as a method for forming the release layer, a thin film forming method such as a PVD method, a CVD method, a spin coating method, or a dip coating method can be suitably used. By providing the release layer, it is possible to prevent structural damage to the microneedle portion 2 of the needle-like body 1 at the time of release, and to provide a more precise and complete needle-like body 1.

図1c
樹脂12に加熱溶融処理を行う。加熱溶融処理によって、前記(低分子量成分を含ませる)前処理によって樹脂12内に閉じ込められた低分子量成分が気化し、多数の気泡4が発生する。
FIG.
The resin 12 is heated and melted. By the heat melting treatment, the low molecular weight component confined in the resin 12 by the pretreatment (including the low molecular weight component) is vaporized, and a large number of bubbles 4 are generated.

樹脂12を融点近傍の温度に加熱するために、複製版11には加熱機構が備えられていることが望ましい。ここで「加熱機構」とは、例えば、複製版11の裏面に備え付けられたホットプレートのようなものを意味する。他の態様として、例えば、複製版11の内部にシート状のヒーターを備え付けたもの、あるいは、複製版11と樹脂12全体を加熱する温風オーブンのようなものであってもよい。また、別の態様として、上記「加熱機構」を設けず、あらかじめ溶融状態の樹脂を針状体11上に供給してもよい。   In order to heat the resin 12 to a temperature near the melting point, it is desirable that the duplicate plate 11 is provided with a heating mechanism. Here, the “heating mechanism” means, for example, a hot plate provided on the back surface of the duplicate plate 11. As another aspect, for example, a duplicate plate 11 provided with a sheet-like heater, or a warm air oven that heats the duplicate plate 11 and the entire resin 12 may be used. As another aspect, the above-mentioned “heating mechanism” may not be provided, and a molten resin may be supplied onto the needle-like body 11 in advance.

図1d
支持版13によって樹脂12に対して加圧処理を行う。樹脂12の加熱溶融と同時または加熱溶融後、支持版13を樹脂12に押圧することによって、樹脂12内に発生した多数の気泡4は樹脂内に閉じ込められ、かつ針状体1の微小針部2に存在する気泡4を台座部3に移動させることができる。
FIG.
A pressure treatment is performed on the resin 12 by the support plate 13. Simultaneously with heat melting of the resin 12 or after heat melting, by pressing the support plate 13 against the resin 12, many bubbles 4 generated in the resin 12 are confined in the resin, and the microneedle portion of the needle-like body 1 2 can be moved to the base 3.

支持版13は、複製版11と対向する位置に配置され、複製版11に充填された樹脂12を上方から押圧するためのものであり、支持版13は、針状体1の台座部3の厚みを制御するとともに、樹脂11内に発生した多数の気泡4が樹脂11から蒸発することを防ぎ、かつ針状体1の微小針部2に存在する気泡4を台座部3に移動させる役割を有する。   The support plate 13 is disposed at a position facing the duplicate plate 11 and is used to press the resin 12 filled in the duplicate plate 11 from above. The support plate 13 is provided on the base 3 of the needle-like body 1. While controlling the thickness, it prevents a large number of bubbles 4 generated in the resin 11 from evaporating from the resin 11 and moves the bubbles 4 existing in the microneedle portion 2 of the needle-like body 1 to the pedestal portion 3. Have.

支持版13は、樹脂12の台座形成部の厚制御性、耐久性および離型性などを考慮した材質で作製されている。支持版13の材質は、特に限定するものではないが、複製版11の材質と同様、銅、ニッケル、シリコン、鉄、アルミ、チタン、クロム、およびこれらを任意の比率で含む合金、ガラス質物質、あるいはテフロン(登録商標)樹脂、シリコーン樹脂、などから選択される。   The support plate 13 is made of a material that takes into account the thickness controllability, durability, releasability, and the like of the base forming portion of the resin 12. Although the material of the support plate 13 is not particularly limited, like the material of the duplicate plate 11, copper, nickel, silicon, iron, aluminum, titanium, chromium, and alloys and vitreous materials containing these in any ratio Or Teflon (registered trademark) resin, silicone resin, or the like.

図1e
支持版13による加圧後、鋳型全体を急冷して樹脂12を硬化させる。樹脂12を硬化させることによって、樹脂12内に閉じ込められた気泡4は空孔4として固定される。支持版13を樹脂から切り離し、複製版11上で成型された樹脂12を複製版11から剥離することによって、台座部3に空孔4が偏在した針状体1を得ることができる。
FIG.
After pressurization by the support plate 13, the entire mold is rapidly cooled to cure the resin 12. By curing the resin 12, the bubbles 4 confined in the resin 12 are fixed as the holes 4. By separating the support plate 13 from the resin and separating the resin 12 molded on the replication plate 11 from the replication plate 11, the needle-like body 1 in which the holes 4 are unevenly distributed in the pedestal portion 3 can be obtained.

第1の実施態様において作製された針状体1は、台座部1に空孔4が多数存在するため、水蒸気透過性能に優れ、針状体1の貼付領域において蒸れにくく、長時間にわたって貼り付けても皮膚炎症が生じにくい。また、空孔4は台座部3に偏在しており、微小針部2に存在する空孔4は極めて少ないため、前記空孔4が針状体1の薬剤投与能に何ら悪影響を及ぼすことなく、結果として、既存の針状体の薬剤投与能を失うことなく、高い水蒸気透過性能を備えた優れた針状体を提供することができる。   Since the needle-shaped body 1 manufactured in the first embodiment has a large number of holes 4 in the pedestal portion 1, the needle-shaped body 1 is excellent in water vapor transmission performance, hardly sticks in the pasting area of the needle-shaped body 1, and is stuck for a long time However, skin irritation hardly occurs. In addition, since the holes 4 are unevenly distributed in the pedestal portion 3 and there are very few holes 4 in the microneedle portion 2, the holes 4 do not adversely affect the drug administration ability of the needle-like body 1. As a result, it is possible to provide an excellent needle-like body having high water vapor transmission performance without losing the drug administration ability of the existing needle-like body.

また、第1の実施態様における方法は、台座部3に空孔4が偏在した複雑な針状体の製造方法であるにもかかわらず、微小針部2と台座部3に異なる素材を用いることなく、微小針部2と台座部3とを単一の樹脂から一体成型して作製することができる。その結果、成型工程が単純になり、針状体の生産性の向上に寄与する。   Moreover, although the method in the first embodiment is a manufacturing method of a complicated needle-like body in which the holes 4 are unevenly distributed in the pedestal portion 3, different materials are used for the microneedle portion 2 and the pedestal portion 3. The microneedle portion 2 and the pedestal portion 3 can be integrally molded from a single resin. As a result, the molding process is simplified, which contributes to the improvement of the productivity of the needle-shaped body.

さらにまた、針状体1が空孔4を多数含むことにより、使用する樹脂量が減少するので、大量生産現場において原材料費の低減に寄与する。   Furthermore, since the needle-like body 1 includes many holes 4, the amount of resin to be used is reduced, which contributes to a reduction in raw material costs at a mass production site.

図2
図2は、第1の実施態様における方法によって作製された針状体の断面図である。
FIG.
FIG. 2 is a cross-sectional view of a needle-like body produced by the method according to the first embodiment.

図2中、針状体1は、微小針部2および台座部3を備え、台座部3には微小な空孔4が高密度で多数存在している。   In FIG. 2, the needle-like body 1 includes a minute needle portion 2 and a pedestal portion 3, and a large number of minute holes 4 exist in the pedestal portion 3 at a high density.

第1の実施態様における方法によって作製された針状体1は、皮膚を穿孔するための十分な細さと先端角、および皮下に薬液を浸透させるための十分な長さを有している。具体的には、特に限定するものではないが、微小針部2の直径は数μmから数百μm、その先端角は30°以下であることが望ましい。続いて、微小針部2の長さは、皮膚の最外層である角質層を貫通する長さが望ましい。角質層の厚さは人体の部位によっても若干異なるが、平均して20μm程度である。角質層の下には約200μmから約350μmの厚さの表皮が存在し、さらにその下層には毛細血管が張りめぐる真皮層が存在する。このため、角質層を貫通させ薬液を浸透させるためには少なくとも約20μm以上の針状体の長さであればよい。一方、血中投与を目的とする場合には、少なくとも約200μm以上の針状体の長さであればよい。なお、微小針部2の針状体1における密度は、十分に薬剤を浸透させるために、好ましくは1平方センチメートルあたり100本以上1500本以下、さらに好ましくは300本以上である。   The needle-like body 1 produced by the method in the first embodiment has a sufficient fineness and a tip angle for piercing the skin, and a sufficient length for allowing the drug solution to penetrate subcutaneously. Specifically, although not particularly limited, it is desirable that the diameter of the microneedle portion 2 is several μm to several hundred μm, and the tip angle thereof is 30 ° or less. Subsequently, the length of the microneedle portion 2 is preferably a length that penetrates the stratum corneum that is the outermost layer of the skin. The thickness of the stratum corneum varies slightly depending on the part of the human body, but is about 20 μm on average. Under the stratum corneum is an epidermis having a thickness of about 200 μm to about 350 μm, and there is a dermis layer under which capillaries are stretched. For this reason, in order to penetrate the stratum corneum and allow the chemical solution to penetrate, the length of the needle-like body of at least about 20 μm or more is sufficient. On the other hand, for the purpose of administration in blood, the length of the needle-shaped body should be at least about 200 μm or more. In addition, the density in the needle-like body 1 of the microneedle portion 2 is preferably 100 or more and 1500 or less, more preferably 300 or more per square centimeter, in order to sufficiently penetrate the drug.

また、第1の実施態様における方法によって作製された針状体1は、微小針部2が構造的安定性を有し、台座部3の変形に起因した微小針部2同士の接触によって引き起こされる微小針部2の針先の損傷が抑制される。具体的構成として、特に限定するものではないが、台座部3の厚さは、好ましくは100μm以上1cm以下、さらに好ましくは800μm以上5mm以下である。   Further, in the needle-like body 1 produced by the method in the first embodiment, the microneedle portion 2 has structural stability and is caused by contact between the microneedle portions 2 due to deformation of the pedestal portion 3. Damage to the needle tip of the microneedle portion 2 is suppressed. Although it does not specifically limit as a specific structure, The thickness of the base part 3 becomes like this. Preferably they are 100 micrometers or more and 1 cm or less, More preferably, they are 800 micrometers or more and 5 mm or less.

さらにまた、第1の実施態様における方法によって作製された針状体1は、皮膚刺激につながる発汗による蒸れを防ぐために、十分な気体透過性能、特に、十分な水蒸気透過性能を有している。具体的構成として、台座部3に高密度で多数存在する空孔4が上記特性を針状体1に与える。空孔4は、特に限定するものではないが、その平均直径が好ましくは0.1μm以上500μm以下であり、さらに好ましくは1μm以上50μm以下である。上記平均直径を有する空孔4は、台座部3に水蒸気に対する透過能を付与し、針状体1の貼付箇所における汗の蒸発を促進する。また、上記平均直径は水蒸気透過性能のみを付与し、穿刺部の外気接触による細菌感染などを防ぎ、かつ針状体の構造的強度を十分に確保できる。続いて、空孔4相互間の距離、すなわち、平均空孔間距離は、特に限定するものではないが、1μm以上100μm以下であることが望ましい。上記平均空孔間距離によって、極めて高い水蒸気透過性能が付与され、かつ針状体の構造的高度を十分に確保できる。さらにまた、空孔4は、独立気泡であることが好ましい。ここで「独立気泡である」とは、台座部3を顕微鏡下で観察したときに所定の領域内に存在する独立気泡が連続気泡の数よりも多いことを意味する。独立気泡は、連続気泡に比べて、表面に付着した水分や外気中の細菌が針状体の針側に入り込みにくく、細菌感染などの皮膚疾患をより効果的に防ぐことができる。   Furthermore, the needle-like body 1 produced by the method according to the first embodiment has sufficient gas permeation performance, particularly sufficient water vapor permeation performance, in order to prevent stuffiness due to perspiration that leads to skin irritation. As a specific configuration, a large number of holes 4 present at high density in the pedestal portion 3 impart the above characteristics to the needle-like body 1. The pores 4 are not particularly limited, but the average diameter is preferably 0.1 μm or more and 500 μm or less, and more preferably 1 μm or more and 50 μm or less. The holes 4 having the above average diameter impart water permeability to the pedestal portion 3 and promote the evaporation of sweat at the location where the needle-like body 1 is applied. Moreover, the average diameter provides only water vapor transmission performance, prevents bacterial infection due to external air contact of the puncture portion, and can sufficiently ensure the structural strength of the needle-like body. Subsequently, the distance between the holes 4, that is, the average distance between the holes is not particularly limited, but is preferably 1 μm or more and 100 μm or less. By the average distance between the holes, extremely high water vapor transmission performance is imparted, and the structural height of the needle-like body can be sufficiently secured. Furthermore, the holes 4 are preferably closed cells. Here, “being closed cells” means that the number of closed cells existing in a predetermined region is larger than the number of open cells when the pedestal 3 is observed under a microscope. Compared to open cells, closed cells make it difficult for moisture adhering to the surface and bacteria in the outside air to enter the needle side of the needle-like body, and can effectively prevent skin diseases such as bacterial infection.

シリコンウェハ上に微細凹部がパターニングされた複製版、および鉄製の支持版を用いて針状体を作製した。凹部の最高開口部のサイズはおよそ200μmであり、凹部の深さはおよそ300μmであった。また、1平方センチメートルあたりの凹部の個数は800本であった。また、このシリコンウェハ上に離型剤をコートし、離型性を向上させた。   The acicular body was produced using the replica plate by which the fine recessed part was patterned on the silicon wafer, and the iron support plate. The size of the maximum opening of the recess was approximately 200 μm, and the depth of the recess was approximately 300 μm. The number of recesses per square centimeter was 800. In addition, a release agent was coated on the silicon wafer to improve the release property.

澱粉樹脂バイオプラス HSCP(Zhejiang Hisun Chemical社製)を温度40℃、湿度90%の環境下に3日静置させた。この樹脂を用い、200℃にて加熱溶融後に複製版内へ導入し、複製版の凹部にHSCPを充填させた。支持版をHSCP上から10kgf/cmの圧力で2秒間加圧した後、2kgf/cmの圧力で10秒間さらに加圧した。その後、支持版が樹脂上に接触した状態で静置し、鋳型全体を窒素ブローによって急冷後、支持版を外し、作製された針状体を複製版から剥離した。得られた針状体の台座部の厚さはおよそ800μmであった。 Starch resin bioplus HSCP (manufactured by Zhejiang Hisun Chemical) was allowed to stand in an environment of a temperature of 40 ° C. and a humidity of 90% for 3 days. Using this resin, it was heated and melted at 200 ° C. and then introduced into a replica plate, and the concave portion of the replica plate was filled with HSCP. After pressurizing 2 seconds supporting plate pressure 10 kgf / cm 2 from the HSCP, it was further pressurized for 10 seconds at a pressure of 2 kgf / cm 2. Thereafter, the support plate was left in contact with the resin, the entire mold was quenched with nitrogen blow, the support plate was removed, and the produced needle-like body was peeled from the duplicate plate. The thickness of the pedestal portion of the obtained needle-like body was approximately 800 μm.

得られた針状体の水蒸気透過率をJIS K 7129Bの方法に従って測定した。装置はMocon社製Permatran−W200を用いた。測定条件は38℃90RH%であった。空孔を含んだ針状体の水蒸気透過率は8000g・μm/(m・day)であった。 The water vapor permeability of the obtained needle-like body was measured according to the method of JIS K 7129B. As a device, Permatran-W200 manufactured by Mocon was used. The measurement conditions were 38 ° C. and 90 RH%. The water vapor permeability of the needle-like body including pores was 8000 g · μm / (m 2 · day).

一方、針状体の台座部とほぼ同じ膜厚を有するHSCPフィルム(比較例)の水蒸気透過率は、検出限界以下であった。   On the other hand, the water vapor transmission rate of the HSCP film (comparative example) having substantially the same film thickness as the pedestal of the needle-like body was below the detection limit.

針状体の製造方法を示した模式図Schematic diagram showing the method of manufacturing the needle-shaped body 第1の実施態様における方法によって作製された針状体の断面図Sectional drawing of the acicular body produced by the method in the first embodiment

符号の説明Explanation of symbols

1・・・針状体、2・・・微小針部、3・・・台座部、4・・・気泡、空孔、11・・・複製版、12・・・樹脂、13・・・支持版。 DESCRIPTION OF SYMBOLS 1 ... Acicular body, 2 ... Microneedle part, 3 ... Base part, 4 ... Bubble, hole, 11 ... Duplicate plate, 12 ... Resin, 13 ... Support Edition.

Claims (4)

吸水性樹脂に含水処理を行う前処理工程と、
前記含水処理を受けた吸水性樹脂を、針状体の形状を凹凸反転させた微細な凹部を備える複製版の上面に配置し、当該吸水性樹脂の加熱溶融と同時または加熱溶融後に、前記複製版とこれに対向する支持版との間で、前記含水処理を受けた後に溶融した吸水性樹脂を加圧処理することにより、微小針部と台座部とを備えた針状体に成型するとともに、前記吸水性樹脂内の水分を気化して多数の気泡を発生させ、当該気泡を前記台座部に移動させ、前記台座部に空孔が偏在した針状体とする工程と、
を含む、針状体の製造方法。
A pretreatment step of performing water treatment on the water absorbent resin;
The water-absorbing resin that has been subjected to the water-containing treatment is disposed on the upper surface of a replication plate having fine concave portions in which the shape of the needle-like body is inverted, and at the same time as or after the heat-melting of the water-absorbing resin , By molding the water-absorbing resin that has been melted after being subjected to the water-containing treatment between the duplicate plate and the supporting plate opposite thereto, it is molded into a needle-like body having a microneedle portion and a pedestal portion. And the process of vaporizing the water in the water-absorbent resin to generate a large number of bubbles, moving the bubbles to the pedestal portion, and forming a needle-like body in which holes are unevenly distributed in the pedestal portion;
A method for producing a needle-like body.
吸水性樹脂を、針状体の形状を凹凸反転させた微細な凹部を備える複製版の上面に配置し、当該吸水性樹脂を加熱溶融し、この加熱溶融中に前記吸水性樹脂に含水処理を行う工程と、
前記加熱溶融と同時または加熱溶融後に、前記複製版とこれに対向する支持版との間で、前記加熱溶融中に含水処理を受けた吸水性樹脂を加圧処理することにより、微小針部と台座部とを備えた針状体に成型するとともに、前記吸水性樹脂内の水分を気化して多数の気泡を発生させ、当該気泡を前記台座部に移動させ、前記台座部に空孔が偏在した針状体とする工程と、
を含む、針状体の製造方法。
The water-absorbing resin is placed on the upper surface of the replication plate having fine concave portions in which the shape of the needle-like body is inverted, and the water-absorbing resin is heated and melted. A process of performing;
The heating and melting simultaneously with or after heating melted, between the support plate facing the and to this duplication plate, by a water-absorbent resin having undergone the water treatment in the heating and melting to pressure treatment, the microneedles portion And forming a needle-like body having a pedestal portion, vaporizing moisture in the water-absorbent resin to generate a large number of bubbles, moving the bubbles to the pedestal portion, and providing holes in the pedestal portion. A step of making the needle-like body unevenly distributed;
A method for producing a needle-like body.
吸水性樹脂を、針状体の形状を凹凸反転させた微細な凹部を備える複製版の上面に配置する工程と、
前記吸水性樹脂の加熱溶融と同時または加熱溶融後に、前記複製版と対向し水分を含浸した支持版を前記吸水性樹脂に接触させ、当該吸水性樹脂に含水処理を行う工程と、
前記複製版とこれに対向する支持版との間で、前記吸水性樹脂を加圧処理することにより、微小針部と台座部とを備えた針状体に成型するとともに、前記吸水性樹脂内の水分を気化して多数の気泡を発生させ、当該気泡を前記台座部に移動させ、前記台座部に空孔が偏在した針状体とする工程と、
を含む、針状体の製造方法。
Arranging the water-absorbing resin on the upper surface of the replication plate provided with fine concave portions obtained by reversing the shape of the needle-like body;
After heating and melting the same time or heating and melting of the water-absorbent resin, a support plate impregnated with the duplication plate opposed to the water in contact with the water-absorbent resin, and performing water treatment to the water-absorbent resin,
The water-absorbing resin is subjected to pressure treatment between the duplicate plate and the supporting plate opposite thereto to form a needle-like body having a microneedle portion and a pedestal portion. Vaporizing the water to generate a large number of bubbles, moving the bubbles to the pedestal portion, and forming a needle-like body in which holes are unevenly distributed in the pedestal portion;
A method for producing a needle-like body.
請求項1〜3のいずれか1項に記載の方法によって製造された針状体。 The acicular body manufactured by the method of any one of Claims 1-3 .
JP2008324052A 2008-12-19 2008-12-19 Manufacturing method of needle-shaped body Active JP5572310B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008324052A JP5572310B2 (en) 2008-12-19 2008-12-19 Manufacturing method of needle-shaped body

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008324052A JP5572310B2 (en) 2008-12-19 2008-12-19 Manufacturing method of needle-shaped body

Publications (2)

Publication Number Publication Date
JP2010142473A JP2010142473A (en) 2010-07-01
JP5572310B2 true JP5572310B2 (en) 2014-08-13

Family

ID=42563513

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008324052A Active JP5572310B2 (en) 2008-12-19 2008-12-19 Manufacturing method of needle-shaped body

Country Status (1)

Country Link
JP (1) JP5572310B2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6155539B2 (en) * 2011-12-02 2017-07-05 凸版印刷株式会社 Needle-like body manufacturing method and needle-like body transfer plate
EP2921201B1 (en) * 2012-11-13 2019-12-25 FUJIFILM Corporation Molding compact, and manufacturing method for transdermal absorption sheet
JP5806701B2 (en) * 2013-05-07 2015-11-10 日本写真印刷株式会社 Method for producing transdermal patch and transdermal patch
EP3006078B1 (en) * 2013-06-03 2020-10-07 Toppan Printing Co., Ltd. Needle body manufacturing method
CN103301563B (en) * 2013-06-20 2016-03-23 吴传斌 Soluble coaxial-cone multi-layer micropin, microneedle array and preparation method thereof
JP6285277B2 (en) 2014-05-15 2018-02-28 富士フイルム株式会社 Transdermal absorption sheet and method for producing percutaneous absorption sheet
JP6317690B2 (en) 2015-03-03 2018-04-25 富士フイルム株式会社 Transdermal absorption sheet and method for producing the same
JP6482323B2 (en) 2015-03-03 2019-03-13 富士フイルム株式会社 Transdermal absorption sheet
CN104921961B (en) * 2015-05-25 2017-11-17 成都凤磐生物科技有限公司 A kind of degradable biological microneedle patch of multiple-effect reparation
CN106902453B (en) * 2017-03-07 2019-11-29 莆田学院 A kind of needle body is solvable and the insoluble microneedle preparation method of substrate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006341089A (en) * 2005-05-13 2006-12-21 Fujikura Ltd Instrument for carrying medicinal material and manufacturing method of the same
DE102006028781A1 (en) * 2006-06-23 2007-12-27 Robert Bosch Gmbh Process for making porous microneedles and their use

Also Published As

Publication number Publication date
JP2010142473A (en) 2010-07-01

Similar Documents

Publication Publication Date Title
JP5572310B2 (en) Manufacturing method of needle-shaped body
Li et al. Fabrication of gradient porous microneedle array by modified hot embossing for transdermal drug delivery
EP2441437B1 (en) Microneedle device
US10850083B2 (en) Method for manufacturing microneedle by using biocompatible polymer
JP4959363B2 (en) Manufacturing method of needle-shaped body
Chen et al. Rapidly fabricated microneedle arrays using magnetorheological drawing lithography for transdermal drug delivery
CN106853271B (en) Method for producing microstructure
WO2008010681A1 (en) A solid type microneedle and methods for preparing it
JP5717322B2 (en) Method for producing needle array master
WO2016084701A1 (en) Microneedle device
WO2009154411A1 (en) Process for preparing solid microstructures
JP5380965B2 (en) Needle-like body and method for producing needle-like body
JP2009233170A (en) Method for manufacturing sheet with high aspect ratio structure
WO2016140174A1 (en) Transdermal absorption sheet, and method for manufacturing same
Shravanth et al. Microneedles-based drug delivery for the treatment of psoriasis
Sadeqi et al. Cost-effective fabrication of chitosan microneedles for transdermal drug delivery
CN114917465B (en) Self-heating microneedle drug-loaded patch and preparation method thereof
JP2009207733A (en) Needle-like member
JP2009233808A (en) Hollow needle sheet and manufacturing method for the same
JP6255759B2 (en) Micro needle
KR20210050195A (en) Manufacturing method of micro needle
CN116899093A (en) Novel plaster microneedle patch and preparation method thereof
CN114533651A (en) Inactivated virus microneedle vaccine and preparation method and application thereof
Jiawook Manufacturing nanoimprint lithography system to produce efficient microneedles patch for transdermal drug delivery
Song et al. 3D printing redefines microneedle fabrication for transdermal drug delivery

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20100910

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20110527

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130226

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130430

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140603

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140630

R150 Certificate of patent or registration of utility model

Ref document number: 5572310

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250